China: US should curb demand for opioids, not blame China | Inquirer News

China: US should curb demand for opioids, not blame China

/ 04:43 PM December 28, 2017

Yu Haibin - news conference - 28 Dec 2017

Yu Haibin of the China National Narcotics Control Commission speaks during a press conference held in Beijing, China, Thursday, Dec. 28, 2017. Yu said Thursday there was little evidence showing China was the source of much of the chemicals used in the production of the powerful opioid fentanyl. (Photo by NG HAN GUAN / AP)

BEIJING — The United States should look within to cut down demand for opioids which are fueling its deadly drug crisis rather than stressing unsubstantiated claims that China is the major source of these chemicals, a top Chinese drug enforcement official said Thursday.

China and the US have worked to build a close working relationship to fight global flows of illicit synthetic drugs, but their collaboration remains fraught.

Article continues after this advertisement

Yu Haibin of the China National Narcotics Control Commission told reporters there was little evidence showing China was the source of much of the chemicals used in the production of the powerful opioid fentanyl.

FEATURED STORIES

President Donald Trump in November blamed a “flood of cheap and deadly” fentanyl made in China for the deadliest drug epidemic in US history.

“China doesn’t deny that shipments to the US happen, but there isn’t the proof to show how much – whether it’s 20 percent or 80 percent,” said Yu, adding that US authorities have only sent him information about six shipments from China in the past year.

Article continues after this advertisement

He urged the US to share more data and police intelligence with Chinese authorities and said rampant over-prescription of pain medication and lax cultural attitudes toward drugs had fueled massive demand for opioids in the US.

Article continues after this advertisement

Insufficient drug education and the trend in some states of legalizing marijuana have hurt drug enforcement efforts, he said.

Article continues after this advertisement

“As many states decriminalize marijuana, the public’s attitudes and trends of thinking toward drugs will also have a bad effect” on the fight against hard drugs, Yu said.

Chinese officials have been eager to tout their collaboration with American counterparts on drug enforcement as a bright spot in the occasionally rocky relationship.

Article continues after this advertisement

Officials in Beijing said Thursday they busted a fentanyl factory in November and seized 4.7 kilograms (10.36 pounds) of the substance thanks to a tip-off from US Immigration and Customs about a major online purveyor named “Diana” that turned out to be a front for a 19-person drug ring scattered across China.

China wanted to work more closely with US law enforcement, as well as authorities in Mexico, a transshipment point, Yu said.

China has backed a successful US proposal this year to add several fentanyl precursors to a UN list of controlled substances. China has listed the two chemicals, NPP and 44-ANPP, under domestic drug laws, officials said.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

More than 66,000 people in America died of drug overdoses in the year ending May 2017, a jump of 17.4 percent from the year before, according to provisional data from the Centers for Disease Control and Prevention. The CDC reports most cases of fentanyl overdose are linked to illicitly produced batches of the substance.

TAGS: Fentanyl, opioids, Yu Haibin

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.